Related Experiment Video
Updated: Jul 14, 2026
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
Metastasis suppressors and their roles in breast carcinoma
Kedar S Vaidya1, Danny R Welch
1Department of Pathology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Abstract:
Metastasis remains the most deadly aspect of cancer and still evades direct treatment. Clinically and experimentally, primary tumor development and metastasis are distinct processes-locally growing tumors can progress without the development of metastases. The discovery of endogenous molecules that exclusively inhibit metastasis suggests that metastasis is an amenable therapeutic target. By definition, metastasis suppressors inhibit metastasis without inhibiting tumorigenicity and are thus distinct from tumor suppressors. As the biology underlying functional mechanisms of metastasis suppressors becomes clearer, it is evident that metastasis suppressors could be harnessed as direct drug targets, prognostic markers, and to understand the fundamental biology of the metastatic process. Metastasis suppressors vary widely in their cellular localization: they are found in every cellular compartment and some are secreted. In general, metastasis suppressors appear to regulate selectively how cells respond to exogenous signals, by affecting signaling cascades which regulate downstream gene expression. This review briefly summarizes current functional and biochemical data on metastasis suppressors implicated in breast cancer. We also present a schematic integrating known mechanisms for these metastasis suppressors highlighting potential targets for therapeutic intervention.
Insights
Metastasis suppressors are molecules that inhibit cancer spread without affecting tumor growth. Understanding these suppressors offers new therapeutic targets for treating deadly cancer metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastasis is the deadliest aspect of cancer, often evading direct treatment.
- Primary tumor development and metastasis are distinct biological processes.
- Metastasis suppressors are endogenous molecules that specifically inhibit metastasis, not tumorigenicity.
Purpose of the Study:
- To review current functional and biochemical data on metastasis suppressors in breast cancer.
- To highlight metastasis suppressors as potential therapeutic targets and prognostic markers.
- To integrate known mechanisms of metastasis suppressors and identify therapeutic intervention points.
Main Methods:
- Review of existing literature on metastasis suppressors.
- Analysis of functional and biochemical data.
- Schematic integration of known mechanisms.
Main Results:
- Metastasis suppressors are diverse, found in all cellular compartments and some are secreted.
- These suppressors regulate cellular responses to external signals by modulating signaling cascades and gene expression.
- Specific metastasis suppressors implicated in breast cancer have been identified.
Conclusions:
- Metastasis suppressors represent a promising therapeutic target for inhibiting cancer spread.
- Further understanding of metastasis suppressor mechanisms can lead to novel drug development and improved prognostic markers.
- Targeting metastasis suppressors is crucial for understanding and combating the metastatic process in cancer.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:23Abnormal Proliferation